EnWave Reports 2025 Fourth Quarter and Annual 2025 Consolidated Financial Results

December 15, 2025

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated interim financial results for the fourth quarter and fiscal year ended September 30, 2025.

Alle Werte sind in Tausend und in CAD angegeben, sofern nicht anders angegeben.

  • Reported revenue for Q4 2025 of $6,219, an increase of $2,585 relative to the comparable period in the prior year. During the period, the company commissioned one large-scale and six small-scale machines, sold a refurbished 120kW machine, and continued the fabrication of two large-scale machines on contract.
  • Reported Adjusted EBITDA(1) income for Q4 2025 of $1,407, an increase of $957 from the comparable period in the prior year, with the increase driven by machine sales and the production sales mix relative to the comparative period.
  • Reported royalties, excluding exclusivity payments (“Base Royalties”), for Q4 2025 of $481, an increase of $113, or 31% relative to the comparable period in the prior year.  Reported total royalty revenue for Q4 2025 of $481, a decrease of $161 or 25% relative to total royalty revenue in the comparable period in the prior year. The decrease was related to an existing royalty partner that committed to multiple large-scale machines during the fiscal year, deciding not to continue with exclusivity in an unspecified Central American Country.  This partner redeployed capital to a different strategic area to house the recently acquired large-scale machines. The decrease was offset by an increase in Base Royalties due to the expansion of both product sales and REV™ machine capacity utilization.
  • Gross margin for the three months ending Q4 2025 was 41% compared to 40% for the three months ending Q4 2024. The increase in margin was primarily a result of the production mix of large and small machines at various stages of fabrication.
  • Reported an increase in Selling, General & Administrative (“SG&A”) costs, including Research & Development (“R&D”) of $223 for Q4 2025 relative to the comparable period in the prior year, with the increase primarily related to sales personnel, increased tradeshow attendance, and the timing of patent maintenance fees, offset by a decrease in legal and recruitment fees. 

Konsolidierte finanzielle Leistung:

($ '000s)Three months ended September 30,Year ended September 30,
20252024Veränderung in %20252024Veränderung in %
Umsatzerlöse6,2193,63471%13,8298,18169%
Direkte Kosten(3,667) (2,192) 67%(9,193) (5,522)66%
Bruttomarge2,5521,44277%4,6362,65974%
Betriebliche Aufwendungen      
Allgemeines und Verwaltung571604(5%)2,1122,346(10%)
Vertrieb und Marketing55331973%1,9601,46834%
Forschung und Entwicklung3893676%1,5131,4941%
 1,5131,29017%5,5855,3085%
Net income (loss) – continuing operations92858858%(1,534)(2,350)(35%)
Net income (loss) – discontinued operations7(13)(154%)1,116(48)(2,425%)
Adjusted EBITDA(1) Income (loss)1,407450213%309(1,489)(121%)
Income (loss) per share:      
Continuing operations – basic and diluted   $ 0.01$ (0.01) $ (0.01)$ (0.02) 
Aufgegebene Geschäftsbereiche - unverwässert und verwässert   $ 0.00$ 0.01   $ 0.01$ 0.00 
Unverwässert und verwässert   $ 0.01$ 0.00   $ 0.00$ (0.02) 

Note: (1) Adjusted EBITDA is a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures disclosure below for a reconciliation to the nearest IFRS equivalent.

EnWave’s annual consolidated financial statements and MD&A are available on SEDAR+ at www.sedarplus.ca and on the Company’s website www.enwave.net.

Key Financial Highlights for the Year Ended 2025 (expressed in 000’s)

  • Revenue for the year ended 2025 of $13,829, compared to $8,181 for the year ended 2024, an increase of $5,648. The increase was primarily due to increased equipment construction contract revenue, small-scale machine sales and tolling fees.  
  • Adjusted EBITDA income (refer to Non-IFRS Financial Measures section below) for the year ended 2025 was $309, compared to a loss of $1,489 for the year ended 2024, an improvement of $1,798. The increase in adjusted EBITDA was primarily due to higher machine sales relative to fiscal 2024.
  • Base Royalties were $1,812 for the year ended 2025, an increase of $228 or 14% as compared to the prior year. Total royalty revenue for the year ended 2025 was $1,945 compared to $1,961 for the year ended 2024, a decrease of $16 or 1%. The decrease is a result of lower exclusivity payments offset by an increased number of royalty partners and the expansion of both product sales and REV™ machine capacity utilization.
  • Gross margin for the year ended 2025 was 34% compared to 33% for the year ended 2024. The increase in margin was primarily a result of the production mix of large and small machines at various stages of fabrication.
  • SG&A expenses (including R&D) for the year ended 2025 were $5,585, compared to $5,308 for the year ended 2024, an increase of $277. The increase is primarily related to increased tradeshow attendance, marketing activities, and sales personnel offset by reduced legal costs and professional fees.

Significant Corporate Accomplishments in Q4 2025 and Subsequently:

  • Signed a CLA and equipment purchase agreements for two 10kW REV™ machines and one 60kW REV™ machine with Milne MicroDried®.
  • Signed an equipment purchase agreement with Dairy Concepts for two additional 10kW REV™ machines to expand dairy snack production in Europe.
  • Signed an equipment purchase agreement for a 120kW REV™ machine and a license amendment with BranchOut Food Inc.
  • Signed an equipment purchase agreement for a 10kW REV™ machine and a CLA with Solve Solutions Ltda. 
  • Signed a CLA with a U.S. snack company and an equipment purchase agreement for a 10kW REV™ machine.
  • Signed a CLA with Shinyway International Limited, a service provider of cannabis processing based in New Zealand.
  • Closed a fully subscribed private placement of 7,500,000 common shares of the company at a price per common share of $0.40, raising aggregate gross proceeds of $3,000. 

Nicht-IFRS-Finanzkennzahlen:

This news release refers to Adjusted EBITDA which is a non-IFRS financial measure. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery and non-recurring income and expenses, restructuring and severance charges, and discontinued operations. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the reconciliation between Adjusted EBITDA and the most comparable IFRS financial measure reported in the Company’s consolidated financial statements.

 Drei Monate zum 30. September,Jahr bis 30. September
 ($ '000s) 20252024 20252024
Net income (loss) after income tax935575(418)(2,398)
Amortisation und Abschreibung3682981,2581,160
Aktienbasierte Vergütung5930389248
Fremdwährungs(gewinn)verlust(66)35(13)(1)
Finanzielle Einnahmen19(63)(84)(211)
Finanzaufwand9937304140
Non-recurring income-(475)(11)(475)
Aufgegebene Geschäftsbereiche(7)13(1,116)48
Bereinigtes EBITDA1,407450309(1,489)

Non-IFRS financial measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company’s operating results, underlying performance and prospects in a manner similar to EnWave’s management.  Accordingly, these non-IFRS financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. For more information, please refer to the Non-IFRS Financial Measures section in the Company’s MD&A available on SEDAR+ www.sedarplus.ca.


Über EnWave

EnWave ist weltweit führend in der Innovation und Anwendung der Vakuum-Mikrowellentrocknung. Von seinem Hauptsitz in Delta, BC, aus hat EnWave ein solides Portfolio an geistigem Eigentum entwickelt, seine Radiant Energy Vacuum (REV™)-Technologie perfektioniert und eine innovative Idee in eine bewährte, konsistente und skalierbare Trocknungslösung für die Lebensmittel-, Pharma- und Cannabisindustrie umgewandelt, die herkömmliche Trocknungsmethoden in Bezug auf Effizienz, Kapazität, Produktqualität und Kosten bei weitem übertrifft.

With more than fifty partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

Die Strategie von EnWave besteht darin, lizenzpflichtige kommerzielle Lizenzen mit Lebensmittelherstellern zu unterzeichnen, die besser, schneller und wirtschaftlicher als mit Gefriertrocknung, Gestelltrocknung und Lufttrocknung trocknen wollen und von den folgenden Vorteilen profitieren: Herstellung aufregender neuer Produkte, bis zu siebenmal schnelleres Erreichen des optimalen Feuchtigkeitsgehalts und Verbesserung von Geschmack, Textur, Farbe und Nährwert der Produkte.

Erfahren Sie mehr unter EnWave.net.

EnWave Gesellschaft

Herr Brent Charleton, CFA

Präsident und Geschäftsführer

Für weitere Informationen:

Brent Charleton, CFA, Präsident und CEO unter +1 (778) 378-9616
E-Mail: bcharleton@enwave.net      

Dylan Murray, CPA, CA, CFO unter +1 (778) 870-0729
E-Mail: dmurray@enwave.net  

Safe Harbour für zukunftsgerichtete Informationen: Diese Pressemitteilung kann zukunftsgerichtete Informationen enthalten, die auf den Erwartungen, Schätzungen und Prognosen der Geschäftsleitung basieren. Alle Aussagen, die sich auf Erwartungen oder Prognosen über die Zukunft beziehen, einschließlich Aussagen über die Wachstumsstrategie des Unternehmens, die Produktentwicklung, die Marktposition, die erwarteten Ausgaben und die erwarteten Synergien nach dem Abschluss der Transaktion, sind zukunftsgerichtete Aussagen. Für die Richtigkeit aller Angaben Dritter, auf die in dieser Mitteilung Bezug genommen wird, wird keine Gewähr übernommen. Alle Verweise Dritter auf Marktinformationen in dieser Mitteilung sind ohne Gewähr, da das Unternehmen die ursprünglichen Primärrecherchen nicht durchgeführt hat. Diese Aussagen sind keine Garantie für zukünftige Leistungen und beinhalten eine Reihe von Risiken, Ungewissheiten und Annahmen. Obwohl das Unternehmen versucht hat, wichtige Faktoren zu identifizieren, die dazu führen könnten, dass die tatsächlichen Ergebnisse wesentlich abweichen, kann es andere Faktoren geben, die dazu führen, dass die Ergebnisse nicht wie erwartet, geschätzt oder beabsichtigt ausfallen. Es kann nicht garantiert werden, dass sich solche Aussagen als zutreffend erweisen, da die tatsächlichen Ergebnisse und zukünftigen Ereignisse erheblich von den in solchen Aussagen erwarteten abweichen können. Dementsprechend sollten sich die Leser nicht zu sehr auf zukunftsgerichtete Aussagen verlassen.

Weder die TSX Venture Exchange noch ihr Regulierungsdienstleister (gemäß der Definition dieses Begriffs in den Richtlinien der TSX Venture Exchange) übernehmen die Verantwortung für die Angemessenheit oder Richtigkeit dieser Pressemitteilung.